Episode 28 A Between the Biotech Waves Conversation with Rachel Meyers
Update: 2023-06-16
Description
Today we are talking to Rachel Meyers. Rachel was most recently the CSO of Faze Medicines a company she launched with TRV to focus on the regulation of biomolecular condensates to treat disease. Prior to Faze she was an EIR at TRV prior to which she spent nearly 2 decades at Alnylam. I have had the pleasure of working with Rachel getting an appreciation not only of her as a scientist, entrepreneur and operator but also her pure love of science, focus on company culture and her passion for diversity, equity and inclusion.
Comments
In Channel
Download from Google Play
Download from App Store
United States00:00
00:00
1.0x
